In this study, ginsenoside Rg3 reduced the body weight of diabetic mice by directly binding to PPAR-γ and promoting adiponectin secretion from adipocytes, thereby lowering lipid accumulation and mitochondrial dysfunction in diabetic hearts and ameliorating heart failure. The gene discussed is PPARG; the disease is heart failure.